Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism MEK inhibitors(Dual specificity mitogen-activated protein kinase kinase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CN | 07 Apr 2024 |